Literature DB >> 24271707

The bioavailability of dermatological and other topically administered drugs.

R H Guy1, A H Guy, H I Maibach, V P Shah.   

Abstract

The literature addressing determination of the bioavailability of dermatological and other topically administered drugs has been reviewed. The various methods employed, their advantages and drawbacks, have been identified and evaluated. The state of the art and the success of topical bioavailability assessment are discussed in the light of the information presented. It is concluded that, although current methodology ensures the responsible use of topical medicaments, the techniques are, on the whole, quantitatively inadequate. A number of recommendations are proposed as possible improvements to the approaches now undertaken, and specific measurements for drugs in different therapeutic categories are suggested. The ultimate objective of this survey is to catalyze the establishment of straightforward, objective, quantitative, and reproducible methods to evaluate topical bioavailability and to reduce significantly, thereby, the incidence of bioinequivalence and pharmacological inactivity observed following drug dosing to the skin.

Year:  1986        PMID: 24271707     DOI: 10.1023/A:1016303216873

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  101 in total

1.  Perspectives and problems in cutaneous gerontology.

Authors:  A M Kligman
Journal:  J Invest Dermatol       Date:  1979-07       Impact factor: 8.551

2.  Penetration of drugs through the skin.

Authors:  R B Stoughton
Journal:  Dermatologica       Date:  1976

Review 3.  Optical techniques for monitoring cutaneous microcirculation. Recent applications.

Authors:  R H Guy; E Tur; H I Maibach
Journal:  Int J Dermatol       Date:  1985-03       Impact factor: 2.736

4.  Griseofulvin levels in stratum corneum. Study after oral administration in man.

Authors:  W L Epstein; V P Shah; S Riegelman
Journal:  Arch Dermatol       Date:  1972-09

5.  Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.

Authors:  R J Scheuplein
Journal:  J Invest Dermatol       Date:  1965-11       Impact factor: 8.551

6.  Objective determination of the bioavailability of dermocorticoids--influence of the formulation.

Authors:  M C Poelman; J L Leveque; F Le Gall
Journal:  Br J Dermatol       Date:  1984-07       Impact factor: 9.302

7.  Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine.

Authors:  D Southwell; B W Barry
Journal:  J Invest Dermatol       Date:  1983-06       Impact factor: 8.551

8.  Isolation and lipid biochemical characterization of stratum corneum membrane complexes: implications for the cutaneous permeability barrier.

Authors:  S Grayson; P M Elias
Journal:  J Invest Dermatol       Date:  1982-02       Impact factor: 8.551

9.  Concentration-dependent enhancement of 1-dodecylazacycloheptan-2-one on the percutaneous penetration kinetics of triamcinolone acetonide.

Authors:  D S Chow; I Kaka; T I Wang
Journal:  J Pharm Sci       Date:  1984-12       Impact factor: 3.534

10.  Percutaneous absorption in man: a kinetic approach.

Authors:  R H Guy; J Hadgraft; H I Maibach
Journal:  Toxicol Appl Pharmacol       Date:  1985-03-30       Impact factor: 4.219

View more
  3 in total

1.  Drug transport from thin applications of topical dosage forms: development of methodology.

Authors:  W J Addicks; G L Flynn; N Weiner; C M Chiang
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

2.  Validation of reflectance infrared spectroscopy as a quantitative method to measure percutaneous absorption in vivo.

Authors:  N Higo; A Naik; D B Bommannan; R O Potts; R H Guy
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

3.  Validation of a flow-through diffusion cell for use in transdermal research.

Authors:  W J Addicks; G L Flynn; N Weiner
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.